Echocardiography Findings in Patients With Myocardial Fibrosis and Severe Aortic Stenosis
NCT ID: NCT07331116
Last Updated: 2026-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2014-04-10
2021-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The patients also had cardiac magnetic resonance imaging performed, for a non-invasive quantification of myocardial fibrosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantification of Myocardial Fibrosis in Aortis Stenosis
NCT06571175
Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy
NCT06372301
Non-invasive Diagnosis of Coronary Artery Stenoses by Doppler Echocardiography
NCT00281346
Biological Variation of Cardiac Biomarkers in Aortic Valve Stenosis
NCT02510482
Clinical Value of Stress Echocardiography in Moderate Aortic Stenosis
NCT02792452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Echocardiography and endomyocardial biopsy have been performed in close proximity in time. Due to a small sample size and a large number of echocardiography measurements being possible, only a limited number of prespecified comparisons are performed.
Cardiac magnetic resonance (CMR) was also performed in patients without contraindication, providing a non-invasive gold standard for diffuse fibrosis and replacement fibrosis. A secondary goal will be to investigate how echocardiography parameters performs compared to CMR in quantifying myocardial fibrosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aortic stenosis with biopsy-verified myocardial fibrosis
Periopererative echocardiography
Cardiac magnetic resonance imaging
Cardiac magnetic resonance imaging was taken on selected patients without contraindications. The CMR protocol was changed midway during study inclusions (May 2017), in order to better be able to quantify myocardial fibrosis.
Transthoracic echocardiography
Transthoracic echocardiography, performed close in time to the endomyocardial biopsy taken during aortic valve replacement procedure
Aortic stenosis without biopsy-verified myocardial fibrosis
Periopererative echocardiography
Cardiac magnetic resonance imaging
Cardiac magnetic resonance imaging was taken on selected patients without contraindications. The CMR protocol was changed midway during study inclusions (May 2017), in order to better be able to quantify myocardial fibrosis.
Transthoracic echocardiography
Transthoracic echocardiography, performed close in time to the endomyocardial biopsy taken during aortic valve replacement procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac magnetic resonance imaging
Cardiac magnetic resonance imaging was taken on selected patients without contraindications. The CMR protocol was changed midway during study inclusions (May 2017), in order to better be able to quantify myocardial fibrosis.
Transthoracic echocardiography
Transthoracic echocardiography, performed close in time to the endomyocardial biopsy taken during aortic valve replacement procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Do not wish to participate in study
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rikshospitalet University Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norwegian University of Science and Technology
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Almaas VM, Haugaa KH, Strom EH, Scott H, Smith HJ, Dahl CP, Geiran OR, Endresen K, Aakhus S, Amlie JP, Edvardsen T. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy. Heart. 2014 Apr;100(8):631-8. doi: 10.1136/heartjnl-2013-304923. Epub 2013 Dec 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/1068b
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.